Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jim Bristow, Kevin Cronin, and J. Patrick Ravenel

Premium

Maverix Biomics has added Jim Bristow to its scientific advisory board.

Bristow is currently the deputy of science at the Department of Energy's Joint Genome Institute where he is responsible for developing and implementing the Community Science Program which provides sequencing and analysis for projects of relevance to DOE missions in energy and environment. He also oversees the JGI's plant, fungal, microbial, and metagenome science programs, and manages JGI’s activities as a user facility. In the past, Bristow has been a faculty member at University of California, San Francisco; and has held leadership positions on several grant review boards and advisory committees for the American Heart Association, the National Institutes of Health, and DOE.


Core Informatics has hired Kevin Cronin as its chief commercial officer.

Cronin brings 25 years of experience leading sales and marketing teams serving pharmaceutical, agrochemical, consumer, and chemical companies. He joins Core from Dassault Systemes BIOVIA (formerly Accelrys) where he was most recently vice president of its North American life science division and, prior to that, was Accelrys vice president for global strategic accounts. He's also worked at Symyx and at NextBio — now owned by Illumina.


Cypher Genomics has hired J. Patrick Ravenel as chief technology officer. In the role, he will help advance Cypher's MantisTM, genome interpretation software as a service offering, and CoralTM, a biomarker discovery service.

Previously Ravenel was the vice president of software development at MedImpact Healthcare Systems. Prior to MedImpact, he had successful exits as a co-founder and a director in the areas of security and distributed transactional caching environments. He holds a B.A. in applied mathematics and scientific programming from the University of California, San Diego.


The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.